Back to search results
NCT00983463

Abundance and Distribution of Lipids and Proteins in Nonalcoholic Fatty Liver Disease (NAFLD)

Enrolling by Invitation
Not specifiedAges 18–65Observational
Vanderbilt University
~45 participants
Updated 2025-12-18 on ClinicalTrials.gov

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
To identify and relatively quantify, using high performance liquid chromatography electrospray ionization mass spectrometry, select lipids and proteins present in human liver biopsies.
Measured over 2 years
+1 more outcome measured

Conditions

Nonalcoholic Fatty Liver Disease

Explore related trials

Nonalcoholic Fatty Liver DiseaseNonalcoholic SteatohepatitisObesity

NCT00983463

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Vanderbilt University Medical Center

    Nashville, Tennesseeno site contact published

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Study leadership

  • Charles R Flynn, PhD · PRINCIPAL_INVESTIGATOR · Vanderbilt University Medical Center
  • Najji Abumrad, MD · STUDY_CHAIR · Vanderbilt University Medical Center

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

18-65 year of age
Undergoing elective abdominal or bariatric surgery
May have normal or elevated ALT/AST levels

Exclusion

Presence of viral hepatitis
Significant alcohol use
Intercurrent infections
Use of any thiazolidinediones

What this trial measures

  • To identify and relatively quantify, using high performance liquid chromatography electrospray ionization mass spectrometry, select lipids and proteins present in human liver biopsies.2 years
  • To spatially profile, using matrix assisted laser desorption ionization time of flight mass spectrometry, select lipids and proteins present in human liver biopsies.2 years